Operating Lease, Right-of-Use Asset of Prime Medicine, Inc. from 01 Jan 2021 to 30 Sep 2025

Taxonomy & unit: us-gaap: USD
Description: Amount of lessee's right to use underlying asset under operating lease.
Summary: Prime Medicine, Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 01 Jan 2021 to 30 Sep 2025.
Prime Medicine, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $117,869,000, a 139% increase year-over-year.
Source SEC data: View on sec.gov

Operating Lease, Right-of-Use Asset, Quarterly (USD)

Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Prime Medicine, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q3 2025	$117,869,000	+$68,505,000	+139%	30 Sep 2025	10-Q	07 Nov 2025	2025	Q3
Q2 2025	$120,203,000	+$68,609,000	+133%	30 Jun 2025	10-Q	07 Aug 2025	2025	Q2
Q1 2025	$125,380,000	+$69,852,000	+126%	31 Mar 2025	10-Q	08 May 2025	2025	Q1
Q4 2024	$47,156,000	+$33,215,000	+238%	31 Dec 2024	10-Q	07 Nov 2025	2025	Q3
Q3 2024	$49,364,000	+$32,094,000	+186%	30 Sep 2024	10-Q	12 Nov 2024	2024	Q3
Q2 2024	$51,594,000	+$25,089,000	+95%	30 Jun 2024	10-Q	08 Aug 2024	2024	Q2
Q1 2024	$55,528,000	+$28,814,000	+108%	31 Mar 2024	10-Q	10 May 2024	2024	Q1
Q4 2023	$13,941,000	-$15,604,000	-53%	31 Dec 2023	10-K	28 Feb 2025	2024	FY
Q3 2023	$17,270,000	-$15,074,000	-47%	30 Sep 2023	10-Q	03 Nov 2023	2023	Q3
Q2 2023	$26,505,000			30 Jun 2023	10-Q	07 Aug 2023	2023	Q2
Q1 2023	$26,714,000			31 Mar 2023	10-Q	11 May 2023	2023	Q1
Q4 2022	$29,545,000	+$18,799,000	+175%	31 Dec 2022	10-K	01 Mar 2024	2023	FY
Q3 2022	$32,344,000			30 Sep 2022	10-Q	14 Nov 2022	2022	Q3
Q4 2021	$10,746,000	+$7,946,000	+284%	31 Dec 2021	10-K	09 Mar 2023	2022	FY
Q4 2020	$2,800,000			01 Jan 2021	10-K	09 Mar 2023	2022	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.